Stay updated on Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page.

Latest updates to the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded a government funding lapse notice and updated version to v3.2.0; removed the previous v3.1.0 tag.SummaryDifference2%
- Check23 days agoChange DetectedVersion update to v3.1.0 with added contact details (new emails and phone numbers) for Mediclinic-related contacts. Deletion of the old revision v3.0.2. If no further context, these are the key changes.SummaryDifference0.1%
- Check38 days agoChange DetectedRevision: v3.0.2 replaces v3.0.1, signaling a new release. The 'Back to Top' link was removed, a minor navigation change.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%
- Check52 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new chemical compounds related to the content. However, many specific medical topics and related terms have been removed.SummaryDifference3%
- Check66 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page.